-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
-
Summary
-
Halozyme Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2015 to 2024.
- Halozyme Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending December 31, 2024 was 127M shares, a 3.87% decline year-over-year.
- Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 127M shares, a 3.87% decline from 2023.
- Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 132M shares, a 3.59% decline from 2022.
- Halozyme Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 137M shares, a 2.7% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)